10-Q
Quarterly Report
SONOMA PHARMACEUTICALS, INC.
SNOA
NASDAQ
CIK: 1367083
File #: 001-33216
Balance Sheet
37 line items · 2 periods
XBRL
| Item | Sep 30, 2025 | Mar 31, 2025 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 3,035,000 | 5,374,000 |
Accounts Receivable | 2,703,000 | 2,232,000 |
Inventory | 3,634,000 | 2,915,000 |
Other Non-Operating Current Assets | 2,925,000 | 1,915,000 |
Current portion of deferred consideration, net of discount | 204,000 | 212,000 |
Total current assets | 12,501,000 | 12,648,000 |
Property, Plant and Equipment | 284,000 | 225,000 |
Operating Lease Right-of-Use Asset | 479,000 | 84,000 |
Deferred Tax Assets, Non-Current | 508,000 | 589,000 |
Deferred consideration, net of discount, less current portion | 0 | 73,000 |
Other Non-Operating Non-Current Assets | 84,000 | 74,000 |
Total assets | 13,856,000 | 13,693,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 1,404,000 | 953,000 |
Accounts Payable | 2,024,000 | 2,224,000 |
Other Current Liabilities | 750,000 | 641,000 |
Short-Term Debt | 56,000 | 220,000 |
Operating Lease Liability, Current | 88,000 | 58,000 |
Total current liabilities | 4,322,000 | 4,096,000 |
Warranty and Other Provisions | 0 | 17,000 |
Withholding tax payable | 5,356,000 | 5,142,000 |
Operating Lease Liability, Non-Current | 391,000 | 27,000 |
Total liabilities | 10,069,000 | 9,282,000 |
Stockholders’ Equity: | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 0 | 0 |
Total Stockholders' Equity | 206,733,000 | 206,593,000 |
Total Stockholders' Equity | (199,581,000) | (197,806,000) |
Total Stockholders' Equity | (3,365,000) | (4,376,000) |
Total stockholders’ equity | 3,787,000 | 4,411,000 |
Additional Paid-in Capital | 206,733,000 | 206,593,000 |
Retained Earnings | (199,581,000) | (197,806,000) |
AOCI Attributable to Parent | (3,365,000) | (4,376,000) |
Total liabilities and stockholders’ equity | 13,856,000 | 13,693,000 |